ACTRN12614000535673招募中3 期
Diosmin plus cabergoline for prevention of Ovarian Hyperstimulation Syndrome in high-risk women undergoing intracytoplasmic sperm injection (ICSI)
khalid abd aziz mohamed0 个研究点目标入组 250 人开始时间: 2014年5月20日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 250
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 23 Years 至 48 Years（—）
- 性别
- Female
入选标准
- •infertile women with or without polcystic ovarian syndrome and candidate forICSI with one of the following:
- •1.Presence of more than 20 follicles by ultrasound
- •2.E2 more than 3000 pg/ml
- •3.Retrieval of more than 15 follicles
排除标准
- 未提供
研究者
相似试验
已完成
3 期
The efficacy of Cabergoline in preventing ovarian hyper stimulation in ART programovarian hyperstimulation syndrome.Other obstetric conditions, not elsewhere classifiedO94, O99IRCT138808271141N7Royan Institute130
已完成
2 期
Diosmin Versus Cabergoline for Prevention of Ovarian Hyperstimulation SyndromeInfertilityNCT02134249Benha University200
尚未招募
4 期
Cabergoline as an Adjunct to Ovulation Induction in Infertile Women with EndometriosisCTRI/2024/03/063714il
进行中（未招募）
1 期
Cabergoline as a Preventive Treatment for Chronic MigraineMedDRA version: 20.0Level: LLTClassification code 10020739Term: HyperprolactinemiaSystem Organ Class: 100000004860MigraineEUCTR2021-005579-38-DKAarhus University Hospital, Department of Endocrinology32
已完成
不适用
Cabergoline and Coasting to Prevent OHSSOHSSNCT01984320Cairo University300